| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
1 Department of Haematology, Barts and The London Queen Marys School of Medicine and Dentistry, London, United Kingdom, and 2 Tianjin Medical University, Tianjin, Peoples Republic of China.
Previous studies have shown that the lymphoblastic leukemia CEM cell line is resistant to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis because of a low expression of caspase-8. Bcl-2 inhibitors, BH3I-2' and HA14-1, are small cell-permeable nonpeptide compounds, are able to induce apoptosis by mediating cytochrome c release, and also lead to dissipation of the mitochondrial membrane potential (
m). This study aimed to use the Bcl-2 inhibitors to sensitize CEM cells to TRAIL-induced apoptosis by switching on the mitochondrial apoptotic pathway. We found that a low dose of BH3I-2' or HA14-1, which did not induce cytochrome c release, greatly sensitized CEM cells to TRAIL-induced apoptosis. In a similar manner to the classical uncoupler carbonyl cyanide m-chlorophenylhydrazone (CCCP), both BH3I-2' and HA14-1 induced a reduction in 
m, a generation of reactive oxygen species (ROS), an increased mitochondrial respiration, and a decreased ATP synthesis. This uncoupling function of the Bcl-2 inhibitors was responsible for the synergy with TRAIL-induced apoptosis. CCCP per se did not induce apoptosis but again sensitized CEM cells to TRAIL-induced apoptosis by uncoupling mitochondrial respiration. The uncoupling effect facilitated TRAIL-induced Bax conformational change and cytochrome c release from mitochondria. Inhibition of caspases failed to block TRAIL-mediated cell death when mitochondrial respiration was uncoupled. We observed that BH3I-2', HA14-1, or CCCP can overcome resistance to TRAIL-induced apoptosis in TRAIL-resistant cell lines, such as CEM, HL-60, and U937. Our results suggest that the uncoupling of mitochondrial respiration can sensitize leukemic cells to TRAIL-induced apoptosis. However, caspase activation per se does not represent an irreversible point of commitment to TRAIL-induced cell death when mitochondrial respiration is uncoupled.
This article has been cited by other articles:
![]() |
F.-T. Liu, S. G. Agrawal, Z. Movasaghi, P. B. Wyatt, I. U. Rehman, J. G. Gribben, A. C. Newland, and L. Jia Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib Blood, November 1, 2008; 112(9): 3835 - 3846. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-T. Liu, S. G. Agrawal, J. G. Gribben, H. Ye, M.-Q. Du, A. C. Newland, and L. Jia Bortezomib blocks Bax degradation in malignant B cells during treatment with TRAIL Blood, March 1, 2008; 111(5): 2797 - 2805. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Prabhakar, N. Mulherkar, and K. V. Prasad Role of IG20 Splice Variants in TRAIL Resistance Clin. Cancer Res., January 15, 2008; 14(2): 347 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Emdad, I. V. Lebedeva, Z.-Z. Su, D. Sarkar, P. Dent, D. T. Curiel, and P. B. Fisher Melanoma differentiation associated gene-7/interleukin-24 reverses multidrug resistance in human colorectal cancer cells Mol. Cancer Ther., November 1, 2007; 6(11): 2985 - 2994. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. H. Psahoulia, K. G. Drosopoulos, L. Doubravska, L. Andera, and A. Pintzas Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts Mol. Cancer Ther., September 1, 2007; 6(9): 2591 - 2599. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kroemer, L. Galluzzi, and C. Brenner Mitochondrial Membrane Permeabilization in Cell Death Physiol Rev, January 1, 2007; 87(1): 99 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-S. Yeow, A. Baras, A. Chua, D. M. Nguyen, S. S. Sehgal, D. S. Schrump, and D. M. Nguyen Gossypol, a phytochemical with BH3-mimetic property, sensitizes cultured thoracic cancer cells to Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand J. Thorac. Cardiovasc. Surg., December 1, 2006; 132(6): 1356 - 1362. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-M. Shen and S. Pervaiz TNF receptor superfamily-induced cell death: redox-dependent execution FASEB J, August 1, 2006; 20(10): 1589 - 1598. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Milanesi, P. Costantini, A. Gambalunga, R. Colonna, V. Petronilli, A. Cabrelle, G. Semenzato, A. M. Cesura, E. Pinard, and P. Bernardi The Mitochondrial Effects of Small Organic Ligands of BCL-2: SENSITIZATION OF BCL-2-OVEREXPRESSING CELLS TO APOPTOSIS BY A PYRIMIDINE-2,4,6-TRIONE DERIVATIVE J. Biol. Chem., April 14, 2006; 281(15): 10066 - 10072. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Manero, F. Gautier, T. Gallenne, N. Cauquil, D. Gree, P.-F. Cartron, O. Geneste, R. Gree, F. M. Vallette, and P. Juin The Small Organic Compound HA14-1 Prevents Bcl-2 Interaction with Bax to Sensitize Malignant Glioma Cells to Induction of Cell Death. Cancer Res., March 1, 2006; 66(5): 2757 - 2764. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Izeradjene, L. Douglas, D. M. Tillman, A. B. Delaney, and J. A. Houghton Reactive Oxygen Species Regulate Caspase Activation in Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Resistant Human Colon Carcinoma Cell Lines Cancer Res., August 15, 2005; 65(16): 7436 - 7445. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, G. L. Borchert, S. P. Donald, A. Surazynski, C.-A. Hu, C. J. Weydert, L. W. Oberley, and J. M. Phang MnSOD inhibits proline oxidase-induced apoptosis in colorectal cancer cells Carcinogenesis, August 1, 2005; 26(8): 1335 - 1342. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Konopleva, E. Elstner, T. J. McQueen, T. Tsao, A. Sudarikov, W. Hu, W. D. Schober, R.-Y. Wang, D. Chism, S. M. Kornblau, et al. Peroxisome proliferator-activated receptor {gamma} and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias Mol. Cancer Ther., October 1, 2004; 3(10): 1249 - 1262. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |